Does SIMVASTATIN Cause Hypercholesterolaemia? 91 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 91 reports of Hypercholesterolaemia have been filed in association with SIMVASTATIN (Simvastatin). This represents 0.3% of all adverse event reports for SIMVASTATIN.
91
Reports of Hypercholesterolaemia with SIMVASTATIN
0.3%
of all SIMVASTATIN reports
20
Deaths
32
Hospitalizations
How Dangerous Is Hypercholesterolaemia From SIMVASTATIN?
Of the 91 reports, 20 (22.0%) resulted in death, 32 (35.2%) required hospitalization, and 20 (22.0%) were considered life-threatening.
Is Hypercholesterolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMVASTATIN. However, 91 reports have been filed with the FAERS database.
What Other Side Effects Does SIMVASTATIN Cause?
Myalgia (3,919)
Fatigue (2,066)
Arthralgia (1,775)
Drug interaction (1,744)
Nausea (1,676)
Rhabdomyolysis (1,616)
Dyspnoea (1,542)
Headache (1,470)
Drug hypersensitivity (1,433)
Muscular weakness (1,356)
What Other Drugs Cause Hypercholesterolaemia?
ALENDRONATE (1,607)
METHOTREXATE (1,547)
TOCILIZUMAB (1,483)
ADALIMUMAB (1,479)
ABATACEPT (1,410)
RITUXIMAB (1,389)
PREDNISONE (1,377)
INFLIXIMAB (1,338)
DICLOFENAC (1,331)
LEFLUNOMIDE (1,322)
Which SIMVASTATIN Alternatives Have Lower Hypercholesterolaemia Risk?
SIMVASTATIN vs SINGULAIR
SIMVASTATIN vs SINTILIMAB
SIMVASTATIN vs SIPONIMOD
SIMVASTATIN vs SIPULEUCEL-T
SIMVASTATIN vs SIROLIMUS